Part 3.3 / M16 (Part 1/4)
3. DEEL 3: GEHARMONISEERDE INDELING EN ETIKETTERING
|
Catalogusnummer |
►M18 Chemische naam ◄ |
EG-nr. |
CAS-nr. |
Indeling |
Etikettering |
►M18 Specifieke concentratiegrenzen, M-factoren en ATE's (*1) ◄ |
Opmerkingen |
|||
|
Gevarenklasse en -categorie |
Gevarenaanduiding |
Pictogram, signaalwoord |
Gevarenaanduiding |
Aanvullende gevarenaanduiding |
||||||
|
005-009-00-3 |
tetrabutylammonium-butyltrifenylboraat |
418-080-4 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
005-010-00-9 |
N, N-dimethylaniliniumtetrakis(pentafluorfenyl)boraat |
422-050-6 |
Carc. 2 Acute Tox. 4 * Skin Irrit. 2 Eye Dam. 1 |
H351 H302 H315 H318 |
GHS08 GHS05 GHS07 Dgr |
H351 H302 H315 H318 |
|
|
|
|
|
005-012-00-X |
diëthyl{4-[1,5,5-tris(4-diëthylaminofenyl)penta-2,4-diënylideen]cyclohexa-2,5-diënylideen}ammonium-butyltrifenylboraat |
418-070-1 |
Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H317 H400 H410 |
GHS07 GHS09 Wng |
H317 H410 |
|
|
|
|
|
005-013-00-5 |
diëthylmethoxyboraan |
425-380-9 |
Pyr. Liq. 1 Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Skin Corr. 1B Skin Sens. 1 Aquatic Chronic 4 |
H250 H332 H312 H302 H373** H314 H317 H413 |
GHS02 GHS05 GHS08 GHS07 Dgr |
H250 H332 H312 H302 H373** H314 H317 H413 |
|
|
|
|
|
005-014-00-0 |
4-formylfenylboronzuur |
438-670-5 |
Skin Sens. 1 |
H317 |
GHS07 Wng |
H317 |
|
|
|
|
|
005-015-00-6 |
1-chloormethyl-4-fluor-1,4-diazoniabicyclo[2.2.2]octaanbis(tetrafluorboraat) |
414-380-4 |
Acute Tox. 4 * Eye Dam. 1 Skin Sens. 1 Aquatic Chronic 3 |
H302 H318 H317 H412 |
GHS05 GHS07 Dgr |
H302 H318 H317 H412 |
|
|
|
|
|
005-016-00-1 |
tetrabutylammonium-butyl-tris-(4-tert-butylfenyl)boraat |
431-370-5 |
— |
Aquatic Chronic 4 |
H413 |
— |
H413 |
|
|
|
|
005-017-00-7 |
natriumperboraat; [1] natriumperoxometaboraat; [2] natriumperoxoboraat; [met < 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
239-172-9 [1] 231-556-4 [2] |
15120-21-5 [1] 7632-04-4 [2] |
Ox. Sol. 2 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H302 H335 H318 |
GHS03 GHS05 GHS08 GHS07 Dgr |
H272 H360Df H302 H335 H318 |
|
Repr.1B; H360Df: C ≥9 % Repr.1B; H360 D: 6,5 % ≤ C <9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
|
|
005-017-01-4 |
natriumperboraat; [1] natriumperoxometaboraat; [2] natriumperoxoboraat; [met ≥ 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
239-172-9 [1] 231-556-4 [2] |
15120-21-5 [1] 7632-04-4 [2] |
Ox. Sol. 2 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H331 H302 H335 H318 |
GHS03 GHS06 GHS05 GHS08 Dgr |
H272 H360Df H331 H302 H335 H318 |
|
Repr. 1B; H360Df: C ≥9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
|
|
005-018-00-2 |
perboorzuur (H3BO2(O2)), mononatriumzout, trihydraat; [1] perboorzuur, natriumzout, tetrahydraat; [2] perboorzuur (HBO(O2)), natriumzout, tetrahydraat; [3] natriumperoxoboraat, hexahydraat; [met < 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
239-172-9 [1] 234-390-0 [2] 231-556-4 [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. 1B STOT SE 3 Eye Dam. 1 |
H360Df H335 H318 |
GHS05 GHS08 GHS07 Dgr |
H360Df H335 H318 |
|
Repr. 1B; H360Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |
|
|
005-018-01-X |
perboorzuur (H3BO2(O2)), mononatriumzout, trihydraat; [1] perboorzuur, natriumzout, tetrahydraat; [2] perboorzuur (HBO(O2)), natriumzout, tetrahydraat; [3] natriumperoxoboraat, hexahydraat; [met ≥ 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
239-172-9 [1] 234-390-0 [2] 231-556-4 [3] |
13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] |
Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H360Df H332 H335 H318 |
GHS05 GHS08 GHS07 Dgr |
H360Df H332 H335 H318 |
|
Repr. 1B; H360 Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |
|
|
005-019-00-8 |
perboorzuur, natriumzout; [1] perboorzuur, natriumzout, monohydraat; [2] perboorzuur (HBO(O2)), natriumzout, monohydraat; [3] natriumperoxoboraat; [met < 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
234-390-0 [1] 234-390-0 [2] 231-556-4 [3] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] |
Ox. Sol. 3 Repr. 1B Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H302 H335 H318 |
GHS03 GHS05 GHS08 GHS07 Dgr |
H272 H360Df H302 H335 H318 |
|
Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
|
|
005-019-01-5 |
perboorzuur, natriumzout; [1] perboorzuur, natriumzout, monohydraat; [2] perboorzuur (HBO(O2)), natriumzout, monohydraat; [3] natriumperoxoboraat; [met ≥ 0,1 % (m/m) deeltjes met een aerodynamische diameter van minder dan 50 μm] |
234-390-0 [1] 234-390-0 [2] 231-556-4 [3] |
11138-47-9 [1] 12040-72-1 [2] 10332-33-9 [3] |
Ox. Sol. 3 Repr. 1B Acute Tox. 3 * Acute Tox. 4 * STOT SE 3 Eye Dam. 1 |
H272 H360Df H331 H302 H335 H318 |
GHS03 GHS06 GHS05 GHS08 Dgr |
H272 H360Df H331 H302 H335 H318 |
|
Repr. 1B; H360Df: C ≥ 9 % Repr. 1B; H360D: 6,5 % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |
|
|
006-001-00-2 |
koolstofmonoxide |
211-128-3 |
Flam. Gas 1 Press. Gas Repr. 1A Acute Tox. 3 * STOT RE 1 |
H220 H360D *** H331 H372 ** |
GHS02 GHS04 GHS06 GHS08 Dgr |
H220 H360D *** H331 H372 ** |
|
|
U |
|
|
006-002-00-8 |
fosgeen; carbonylchloride |
200-870-3 |
Press. Gas Acute Tox. 2 * Skin Corr. 1B |
H330 H314 |
GHS04 GHS06 GHS05 Dgr |
H330 H314 |
|
|
U |
|
|
006-003-00-3 |
koolstofdisulfide |
200-843-6 |
Flam. Liq. 2 Repr. 2 STOT RE 1 Eye Irrit. 2 Skin Irrit. 2 |
H225 H361fd H372 ** H319 H315 |
GHS02 GHS08 GHS07 Dgr |
H225 H361fd H372 ** H319 H315 |
|
Repr. 2; H361fd: C ≥ 1 % STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,2 % ≤ C < 1 % |
|
|
|
006-004-00-9 |
calciumcarbide |
200-848-3 |
Water-react. 1 |
H260 |
GHS02 Dgr |
H260 |
|
|
T |
|
|
006-005-00-4 |
thiram (ISO); tetramethylthiuramdisulfide |
205-286-2 |
Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H332 H302 H373 ** H319 H315 H317 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H332 H302 H373 ** H319 H315 H317 H410 |
|
M = 10 |
|
|
|
006-006-00-X |
waterstofcyanide; cyaanwaterstof; blauwzuur |
200-821-6 |
Flam. Liq. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H224 H330 H400 H410 |
GHS02 GHS06 GHS09 Dgr |
H224 H330 H410 |
|
|
|
|
|
006-006-01-7 |
waterstofcyanide … %; cyaanwaterstof … %; blauwzuur … % |
200-821-6 |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
|
|
B |
|
|
006-007-00-5 |
zouten van waterstofcyanide met uitzondering van complexe cyaniden zoals hexacyanoferraten(II), hexacyanoferraten(III) en kwikoxycyanide, tenzij elders in deze bijlage vermeld |
— |
— |
Acute Tox. 2 * Acute Tox. 1 Acute Tox. 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H310 H300 H400 H410 |
GHS06 GHS09 Dgr |
H330 H310 H300 H410 |
EUH032 |
|
A |
|
006-008-00-0 |
antu (ISO); 1-(1-naftyl)-2-thio-ureum |
201-706-3 |
Acute Tox. 2 * Carc. 2 |
H300 H351 |
GHS06 GHS08 Dgr |
H300 H351 |
|
|
|
|
|
006-009-00-6 |
1-isopropyl-3-methylpyrazool-5-yldimethylcarbamaat; isolan |
204-318-2 |
Acute Tox. 1 Acute Tox. 2 * |
H310 H300 |
GHS06 Dgr |
H310 H300 |
|
|
|
|
|
006-010-00-1 |
5,5-dimethyl-3-oxocyclohex-1-enyldimethylcarbamaat; 5,5-dimethyldihydroresorcinoldimethylcarbamaat; dimetan |
204-525-8 |
Acute Tox. 3 * |
H301 |
GHS06 Dgr |
H301 |
|
|
|
|
|
006-011-00-7 |
carbaryl (ISO); 1-naftylmethylcarbamaat |
200-555-0 |
Carc. 2 Acute Tox. 4 * Acute Tox. 4 * Aquatic Acute 1 |
H351 H332 H302 H400 |
GHS08 GHS07 GHS09 Wng |
H351 H332 H302 H400 |
|
M=100 |
|
|
|
006-012-00-2 |
ziram (ISO); zink-bis(N,N-dimethyldithiocarbamaat) |
205-288-3 |
Acute Tox. 2 * Acute Tox. 4 * STOT RE 2 * STOT SE 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H330 H302 H373 ** H335 H318 H317 H400 H410 |
GHS06 GHS08 GHS05 GHS09 Dgr |
H330 H302 H373 ** H335 H318 H317 H410 |
|
M = 100 |
|
|
|
006-013-00-8 |
metam-natrium (ISO); natrium-N-methyldithiocarbamaat |
205-293-0 |
Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H314 H317 H400 H410 |
GHS05 GHS07 GHS09 Dgr |
H302 H314 H317 H410 |
EUH031 |
|
|
|
|
006-014-00-3 |
nabam (ISO); dinatriumethyleenbisdithiocarbamaat |
205-547-0 |
Acute Tox. 4 * STOT SE 3 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H335 H317 H410 |
GHS07 GHS09 Wng |
H302 H335 H317 H410 |
|
|
|
|
|
006-016-00-4 |
propoxur (ISO); 2-isopropyloxyfenyl-N-methylcarbamaat; 2-isopropoxyfenylmethylcarbamaat |
204-043-8 |
Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H301 H400 H410 |
GHS06 GHS09 Dgr |
H301 H410 |
|
|
|
|
|
006-017-00-X |
aldicarb (ISO); 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxim |
204-123-2 |
Acute Tox. 2 * Acute Tox. 2 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H330 H300 H311 H400 H410 |
GHS06 GHS09 Dgr |
H330 H300 H311 H410 |
|
|
|
|
|
006-018-00-5 |
aminocarb (ISO); 4-dimethylamino-3-tolylmethylcarbamaat |
217-990-7 |
Acute Tox. 3 * Acute Tox. 3 * Aquatic Acute 1 Aquatic Chronic 1 |
H311 H301 H400 H410 |
GHS06 GHS09 Dgr |
H311 H301 H410 |
|
|
|
|
|
006-019-00-0 |
diallaat (ISO); S-(2,3-dichloorallyl)-N,N-diisopropylthiocarbamaat |
218-961-1 |
Carc. 2 Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1 |
H351 H302 H400 H410 |
GHS08 GHS07 GHS09 Wng |
H351 H302 H410 |
|
|
|
|
|
006-020-00-6 |
barban (ISO); 4-chloorbut-2-ynyl-N-(3-chloorfenyl)carbamaat |
202-930-4 |
Acute Tox. 4 * Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 |
H302 H317 H400 H410 |
GHS07 GHS09 Wng |
H302 H317 H410 |
|
|
|
|
|
006-021-00-1 |
linuron (ISO); 3-(3,4-dichloorfenyl)-1-methoxy-1-methylureum |
206-356-5 |
Repr. 1B Carc. 2 Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 Aquatic Chronic 1 |
H360Df H351 H302 H373 ** H400 H410 |
GHS08 GHS07 GHS09 Dgr |
H360Df H351 H302 H373 ** H410 |
|
|
|
|